Ansiowas en es it fr

Ansiowas Brand names, Ansiowas Analogs

Ansiowas Brand Names Mixture

  • No information avaliable

Ansiowas Chemical_Formula


Ansiowas RX_link

No information avaliable

Ansiowas fda sheet

Ansiowas msds (material safety sheet)

Ansiowas Synthesis Reference

No information avaliable

Ansiowas Molecular Weight

309.469 g/mol

Ansiowas Melting Point

< 25 oC

Ansiowas H2O Solubility

Soluble as HCl salt

Ansiowas State


Ansiowas LogP


Ansiowas Dosage Forms

Tablets (oral, 1 mg)

Ansiowas Indication

Used for the symptomatic treatment of parkinsonism.

Ansiowas Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Ansiowas Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Ansiowas side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Ansiowas Patient Information

Ansiowas Organisms Affected

Humans and other mammals